GlassScriptPhysician profile
Ronald L Hammers
NPI 1730340324
$13,096.11
in general payments reported to CMS, 2019-2025
37 companies · $1,443 in 2025
The $1,443 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,487 · 2020: $553 · 2021: $1,595 · 2022: $3,722 · 2023: $1,099 · 2024: $1,197 · 2025: $1,443.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,732 · Consulting Fee: $600 · Travel and Lodging: $408.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,731.64 |
| Consulting Fee | $600.00 |
| Travel and Lodging | $407.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,413.51 | 2021-2025 | Prestige LP Cervical Disc System, Cd Horizon Spinal System, Unid_pass |
| Globus Medical, INC. | $3,257.63 | 2021-2023 | Xtend, Creo 5.5 |
| Medtronic USA, INC. | $3,024.32 | 2019-2020 | |
| Aesculap Implant Systems, LLC | $767.12 | 2019 | |
| Stryker Corporation | $499.58 | 2020-2022 | |
| Abbott Laboratories | $273.16 | 2021-2024 | Infinity |
| Boston Scientific Corporation | $234.85 | 2025 | Wavewriter Alpha Prime 16, Intracept |
| Livanova USA, INC. | $232.90 | 2019-2023 | Vns Therapy Sentiva Model 1000 Generator |
| Nevro Corp. | $153.92 | 2022 | |
| Ucb, INC. | $147.54 | 2021-2023 | Nayzilam, Fintepla |
| Depuy Synthes Sales INC. | $108.43 | 2023-2025 | Symphony, Vivigen Mis Delivery System, Teligen |
| Abbvie INC. | $106.39 | 2023-2025 | |
| Eisai INC. | $91.94 | 2021-2022 | |
| Innovation Technologies INC | $89.94 | 2021 | |
| Avanos Medical | $77.32 | 2021 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $74.35 | 2021-2024 | |
| Tanabe Pharma America, INC. | $65.17 | 2024-2025 | Radicava |
| Teva Pharmaceuticals USA, INC. | $47.79 | 2022-2023 | Austedo Xr |
| Tg Therapeutics, INC. | $35.99 | 2023-2024 | |
| Lemaitre Vascular, INC. | $33.71 | 2019-2021 | |
| Amneal Pharmaceuticals LLC | $28.95 | 2023 | Rytary |
| Sunovion Pharmaceuticals INC. | $28.61 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $27.33 | 2025 | Ultomiris |
| Neuropace, INC. | $25.83 | 2023 | |
| Insightec,INC | $23.47 | 2023 | Exablate |
| Biogen, INC. | $22.61 | 2024 | Skyclarys |
| Spinal Simplicity, LLC | $21.96 | 2022 | |
| Acadia Pharmaceuticals INC | $21.69 | 2023 | Daybue |
| Averitas Pharma INC. | $21.61 | 2023 | Qutenza |
| Csl Behring | $21.35 | 2021 | |
| Ge Healthcare | $20.80 | 2020 | |
| Genentech USA, INC. | $20.52 | 2025 | Ocrevus Zunovo |
| Biohaven Pharmaceuticals, INC. | $19.13 | 2021 | |
| Lilly USA, LLC | $19.07 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $13.90 | 2023 | Nuedexta |
| Misonix INC | $11.92 | 2019 | |
| Cerapedics INC. | $11.80 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Hammers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.